Nehal Chopra

Nehal Chopra's Tiger Ratan Takes $300 Million Hit On Valeant Pharmaceuticals International Inc.

Bill Ackman's hedge fund, Pershing Square Capital Management may be the second biggest owner of Valeant Pharmaceuticals International Inc., but the fund's diversification has helped insulate it (somewhat) from the brunt of the stocks decline. Other hedge funds haven't been so lucky.

According to Reuters, Ackman's Pershing Square reported a decline of 6% to 7% for . . .

SORRY!

This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email support@valuewalk.com and we will get back to you as quick as humanly possible


Saved Articles
X
TextTExtLInkTextTExtLInk

Subscribe to our mailing list

* indicates required

Opt out of occasional 3rd party offers


0